Examples of XenoPort Product in a sentence
Xanodyne agrees to disclose to XenoPort all Improvements made by, or under the authority of, Xanodyne in connection with the development and/or commercialization of the Compound and/or any XenoPort Product under this Agreement.
Xanodyne shall keep XenoPort reasonably informed as to the progress of its development and regulatory activities relating to the Compound and each XenoPort Product in the Territory, by way of updates to the JDC at its meetings, and as otherwise reasonably requested by XenoPort.
In addition, Xanodyne shall promptly provide to XenoPort a copy of all Data and Xanodyne Know-How pertaining to the Compound and all XenoPort Products in the Territory, or otherwise relied upon by Xanodyne in association with any IND, NDA or other approval for the Compound or any XenoPort Product in the Territory, to the extent not previously provided to XenoPort, and XenoPort shall have the right to use and disclose all such Data and Xanodyne Know-How following termination of this Agreement.
Xanodyne may not use any XenoPort Data or other XenoPort Know-How: (i) outside the Territory except as may be necessary, as permitted by and in accordance with Sections 2.1 and 9.3, to manufacture the Intermediate, Compound or any XenoPort Product or develop (excluding performing or having performed clinical trials) the Compound or any XenoPort Product; nor (ii) for any products other than the XenoPort Product.
Xanodyne shall use Commercially Reasonable Efforts to develop, achieve Marketing Approval for, and launch a XenoPort Product for a Menorrhagia Indication in the Territory as soon as practicable, and thereafter to market, promote and sell XenoPort Product(s) and to maximize the Net Sales of XenoPort Products in the Territory.
In addition, the publishing Party shall, at the request of the other Party, remove any Confidential Information of the other Party therefrom, except each Party shall have the right to publicly disclose any information, including Confidential Information, pertaining to safety or efficacy of the Compound and/or any XenoPort Product that such Party believes in good faith it is obligated or ethically bound to disclose.
With respect to any Product Infringement Action related to any Compound or XenoPort Product in the Territory, the following provisions shall apply.
Following Xanodyne's determination in accordance with the preceding sentence that a commercially favorable return in the Territory is reasonably possible for any such Excessive Bleeding Indication(s), and subject to the approval of the JDC (not to be unreasonably withheld), Xanodyne shall use Commercially Reasonable Efforts to develop, achieve Marketing Approval for, and launch a XenoPort Product for such Excess Bleeding Indication(s) in the Territory.
In addition, if (1) the [**] period specified in Section 6.3.2(b)(iii) has expired; (2) paragraphs (i) and (ii) in the preceding sentence are satisfied and (3) [**], in the aggregate, in the Territory in any calendar quarter determined by [**], and Xanodyne reasonably determines that it is not likely to recover such lost market share; then [**] with respect to such XenoPort Product sold in the Territory for such quarter.
The trademarks of Xanodyne, trade dress, style of packaging and the like with respect to each XenoPort Product in the Territory shall be determined by Xanodyne in a manner that is consistent with Xanodyne's standard trade dress and style.